βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells
- PMID: 27207668
- DOI: 10.1093/carcin/bgw058
βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells
Abstract
Non-small cell lung cancer (NSCLC) survival rates are dismal and high βIII-tubulin expression is associated with chemotherapy drug resistance and tumor aggressiveness in this disease. Mounting evidence supports a role for βIII-tubulin in promoting cell survival in the harsh tumor microenvironment, which is characterized by poor nutrient supply. This study aimed to investigate the role of βIII-tubulin in glucose stress response signaling and the survival and proliferation of NSCLC cells. This study revealed that βIII-tubulin regulates cellular metabolism and glucose stress response signaling in NSCLC cells to promote cell survival and proliferation in glucose starvation. βIII-Tubulin decreases the reliance of cells on glycolytic metabolism, priming them to cope with variable nutrient supply present within the tumor microenvironment. βIII-Tubulin protects cells from endoplasmic reticulum (ER) stress and reduces both basal and glucose starvation-induced autophagy to maintain cell survival and proliferation. βIII-Tubulin enables rapid Akt activation in response to glucose starvation and co-immunoprecipitates with the master regulator of the ER stress response GRP78. Furthermore, suppression of βIII-tubulin delays the association of GRP78 with Akt in response to glucose starvation with the potential to influence Akt activation and ER homeostasis under these conditions. Together these results identify that βIII-tubulin regulates glucose metabolism and alters glucose starvation stress signaling to promote cell proliferation and survival in NSCLC cells. This elucidates a hitherto unknown role for this microtubule protein and provides insight into correlations between high βIII-tubulin expression and poor patient outcome in this disease.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer.Cancer Res. 2015 Jan 15;75(2):415-25. doi: 10.1158/0008-5472.CAN-14-2740. Epub 2014 Nov 20. Cancer Res. 2015. PMID: 25414139
-
βIII-tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c-Met positive non-small cell lung cancer cells.Cancer Med. 2023 Feb;12(4):4455-4471. doi: 10.1002/cam4.5128. Epub 2022 Aug 10. Cancer Med. 2023. PMID: 35946957 Free PMC article.
-
Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.Cancer Res. 2007 Oct 1;67(19):9356-63. doi: 10.1158/0008-5472.CAN-07-0509. Cancer Res. 2007. PMID: 17909044
-
The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.Lung Cancer. 2010 Feb;67(2):136-43. doi: 10.1016/j.lungcan.2009.09.007. Epub 2009 Oct 13. Lung Cancer. 2010. PMID: 19828208 Review.
-
[Class III beta tubulin expression in nonsmall cell lung cancer].Rev Mal Respir. 2010 Apr;27(4):383-6. doi: 10.1016/j.rmr.2010.03.006. Epub 2010 Mar 25. Rev Mal Respir. 2010. PMID: 20403547 Review. French.
Cited by
-
The crosstalk among the physical tumor microenvironment and the effects of glucose deprivation on tumors in the past decade.Front Cell Dev Biol. 2023 Nov 1;11:1275543. doi: 10.3389/fcell.2023.1275543. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38020920 Free PMC article. Review.
-
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer.Cancers (Basel). 2023 Apr 7;15(8):2195. doi: 10.3390/cancers15082195. Cancers (Basel). 2023. PMID: 37190124 Free PMC article. Review.
-
Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.J Clin Invest. 2022 Jul 15;132(14):e157410. doi: 10.1172/JCI157410. J Clin Invest. 2022. PMID: 35838048 Free PMC article.
-
Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche.Front Immunol. 2022 May 26;13:876278. doi: 10.3389/fimmu.2022.876278. eCollection 2022. Front Immunol. 2022. PMID: 35693789 Free PMC article. Review.
-
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582143 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
